146 related articles for article (PubMed ID: 7903057)
1. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity.
Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I
Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057
[TBL] [Abstract][Full Text] [Related]
2. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
Murphy WA; Taylor JE; Moreau JP; Coy DH
Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
[TBL] [Abstract][Full Text] [Related]
3. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Teplán I
Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor models.
Tejeda M; Gaál D; Hullán L; Schwab R; Szokoloczi O; Kéri G
Anticancer Res; 2007; 27(6B):4015-9. PubMed ID: 18225564
[TBL] [Abstract][Full Text] [Related]
5. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
6. Continuous administration of the somatostatin structural derivative /TT-232/ by subcutaneously implanted osmotic pump improves the efficacy and potency of antitumor therapy in different mouse and human tumor models.
Tejeda M; Gaal D; Hullán L; Csuka O; Schwab R; Szokoloczi O; Kéri GY
Anticancer Res; 2008; 28(5A):2769-74. PubMed ID: 19035308
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications.
Janecka A; Zubrzycka M
Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935
[TBL] [Abstract][Full Text] [Related]
8. New cyclic somatostatin analogues containing a pyrazinone ring: importance of Tyr for antiproliferative activity.
Miyazaki A; Tsuda Y; Fukushima S; Yokoi T; Vántus T; Bökönyi G; Szabó E; Horváth A; Kéri G; Okada Y
Bioorg Med Chem Lett; 2008 Dec; 18(23):6199-201. PubMed ID: 18930401
[TBL] [Abstract][Full Text] [Related]
9. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
10. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
12. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
[TBL] [Abstract][Full Text] [Related]
13. Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity.
Kéri G; Mezö I; Horváth A; Vadász Z; Balogh A; Idei M; Vántus T; Teplán I; Mák M; Horváth J
Biochem Biophys Res Commun; 1993 Mar; 191(2):681-7. PubMed ID: 8096383
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, conformational analysis and bioactivity of Lan-7, a lanthionine analog of TT-232.
Li H; Jiang X; Howell SB; Goodman M
J Pept Sci; 2000 Jan; 6(1):26-35. PubMed ID: 10674717
[TBL] [Abstract][Full Text] [Related]
15. The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.
Tejeda M; Gaal D; Barna K; Csuka O; Kéri G
Anticancer Res; 2003; 23(5A):4061-6. PubMed ID: 14666719
[TBL] [Abstract][Full Text] [Related]
16. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490
[TBL] [Abstract][Full Text] [Related]
18. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
19. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
